October 10, 2019
Article
The findings of the retrospective cohort study were presented in a poster at IDWeek 2019.
March 09, 2019
The findings of the study were presented in an oral abstract presentation at the Annual Conference on Retroviruses and Opportunistic Infections (CROI 2019) in Seattle, Washington.
February 05, 2019
A New Drug Application (NDA) and a supplemental NDA (sNDA) were accepted for the Priority Review for products being developed by Merck.
September 12, 2018
A new study examining HIV in people who inject drugs found interventions increased use of antiretroviral medication.
September 08, 2018
Officials with the FDA have approved Grifols’ new formulation of immune globulin (GamaSTAN) for hepatitis A virus and measles post-exposure prophylaxis.
September 07, 2018
The new formulation is the only immune globulin available in the United States that is approved for post-exposure protection against hepatitis A and measles.